Video Creative
ABUS Historical Stock Prices ยป
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Arbutus Biopharma is a therapeutic solutions company focused on discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus (HBV) infection. Co.'s HBV pipeline consists of multiple drug candidates, with differing and complementary mechanisms of action. The candidates include: RNAi 1.0 (ARB-1467), which is Co.'s main RNA Interference (RNAi) HBV candidate designed to eliminate HBV surface antigen expression in patients chronically infected with HBV; RNAi 2.0 (ARB-1740), Co.'s follow-on RNAi HBV candidate; and Core Protein/ Capsid Assembly Inhibitors (AB-423), which is being developed as oral therapeutics for the treatment of chronic HBV infection. According to our ABUS split history records, Arbutus Biopharma has had 1 split.
ABUS split history picture
Arbutus Biopharma (ABUS) has 1 split in our ABUS split history database. The split for ABUS took place on November 04, 2010. This was a 1 for 5 reverse split, meaning for each 5 shares of ABUS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.

When a company such as Arbutus Biopharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the ABUS split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Arbutus Biopharma shares, starting with a $10,000 purchase of ABUS, presented on a split-history-adjusted basis factoring in the complete ABUS split history. ABUS split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/23/2008
End date: 01/22/2018
Start price/share: $5.00
End price/share: $5.15
Dividends collected/share: $0.00
Total return: 3.00%
Average Annual Total Return: 0.30%
Starting investment: $10,000.00
Ending investment: $10,304.25
Years: 10.01
Date Ratio
11/04/20101 for 5
ABUS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ACER Split History
ACET Split History
ACHC Split History
ACHV Split History
ACST Split History
ACUR Split History
ADAP Split History
ADK Split History
ADMP Split History
ADMS Split History

Last Articles

direxion financial bull 3x shares seacoast banking corporation of florida who owns tootsie roll industries british american tobacco share price history chipotle mexican grill stock quote fifth third bank stock quote brookfield asset management stock quote canadian natural resources stock quote annaly capital management stock price prudential common stock value today what is the meaning of ifc when does philip morris pay dividends stock quote bank of nova scotia biogen idec stock price history stock quote for sirius xm radio berkshire hathaway historical share price hsbc hk share price history what does a reverse stock split mean aqua america inc stock price blackrock real asset equity trust stock quote for british petroleum td canada trust toronto dominion bank british petroleum share price history

More latest
Latest
Latest

ABUS Insider Buying